The identical 5′ splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect

被引:40
作者
Spirio, L
Green, J
Robertson, J
Robertson, M
Otterud, B
Sheldon, J
Howse, E
Groden, J
White, R
Leppert, M
机构
[1] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA
[3] Mem Univ Newfoundland, Hlth Sci Ctr, Discipline Genet, St Johns, NF A1B 3V6, Canada
[4] New World Isl Clin, Summerford, NF A0G 4E0, Canada
[5] Mem Univ Newfoundland, Hlth Sci Ctr, Fac Med, St Johns, NF A1B 3V6, Canada
[6] Univ Cincinnati, Coll Med, Howard Hughes Med Inst, Cincinnati, OH 45267 USA
[7] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA
关键词
D O I
10.1007/s004390051121
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Inherited mutations of the APC gene predispose carriers to multiple adenomatous polyps of the colon and rectum and to colorectal cancer. Mutations located at the extreme 5' end of the APC gene, however, are associated with a less severe disease known as attenuated adenomatous polyposis coli (AAPC). Many individuals with AAPC develop relatively few colorectal polyps but are still at high risk for colorectal cancer. We report here the identification of a 5' APC germline mutation in five separately ascertained AAPC families from Newfoundland, Canada. This disease-causing mutation is a single basepair change (G to A) in the splice-acceptor region of APC intron 3 that creates a mutant RNA without exon 4 of APC. The observation of the same APC mutation in five families from the same geographic area demonstrates a founder effect. Furthermore, the identification of this germline mutation strengthens the correlation between the 5' location of an APC disease-causing mutation and the attenuated polyposis phenotype.
引用
收藏
页码:388 / 398
页数:11
相关论文
共 60 条
[1]   LOCALIZATION OF THE GENE FOR FAMILIAL ADENOMATOUS POLYPOSIS ON CHROMOSOME-5 [J].
BODMER, WF ;
BAILEY, CJ ;
BODMER, J ;
BUSSEY, HJR ;
ELLIS, A ;
GORMAN, P ;
LUCIBELLO, FC ;
MURDAY, VA ;
RIDER, SH ;
SCAMBLER, P ;
SHEER, D ;
SOLOMON, E ;
SPURR, NK .
NATURE, 1987, 328 (6131) :614-616
[2]  
BURT R, 1995, TXB GASTROENTEROLOGY, V2, P1674
[3]   A NOVEL MUTATION AT THE SPLICE JUNCTION OF EXON-9 OF THE APC GENE IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
CAMA, A ;
ESPOSITO, DL ;
PALMIROTTA, R ;
CURIA, MC ;
RANIERI, A ;
FICARI, F ;
VALANZANO, R ;
MODESTI, A ;
BATTISTA, P ;
TONELLI, F ;
MARIANICOSTANTINI, R .
HUMAN MUTATION, 1994, 3 (03) :305-308
[4]   Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis [J].
Cormier, RT ;
Hong, KH ;
Halberg, RB ;
Hawkins, TL ;
Richardson, P ;
Mulherkar, R ;
Dove, WF ;
Lander, ES .
NATURE GENETICS, 1997, 17 (01) :88-91
[5]  
Curia MC, 1998, HUM MUTAT, V11, P197, DOI 10.1002/(SICI)1098-1004(1998)11:3<197::AID-HUMU3>3.3.CO
[6]  
2-9
[7]  
Dihlmann S, 1999, CANCER RES, V59, P1857
[8]   Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene [J].
Dobbie, Z ;
Spycher, M ;
Mary, JL ;
Haner, M ;
Guldenschuh, I ;
Hurliman, R ;
Amman, R ;
Roth, J ;
Muller, H ;
Scott, RJ .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (04) :274-280
[9]   MUTATIONAL ANALYSIS OF THE FIRST 14 EXONS OF THE ADENOMATOUS POLYPOSIS-COLI (APC) GENE [J].
DOBBIE, Z ;
SPYCHER, M ;
HURLIMAN, R ;
AMMANN, R ;
AMMANN, T ;
ROTH, J ;
MULLER, A ;
MULLER, H ;
SCOTT, RJ .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (11) :1709-1713
[10]  
Eccles DM, 1996, AM J HUM GENET, V59, P1193